TNFRSF10A and cholangiocarcinoma: The changes of expression levels of Fas receptor (FasR/CD95) and TRAIL receptors, including TRAIL-R1 (DR4) and TRAIL-R2 (DR5), were determined on the cell surface of CCA cell lines after treatment with genistein at concentrations of 25, 50, and 100 μM (Supplementary Figure S2 and Figure 6).